Teva's anastrozole label supplement approved; Sanofi duvakitug HS trial still recruitingNov 9Weekly roundup, 2 itemsanastrozoleduvakitug
Teva completes Phase 3 asthma inhaler trial; registers vitiligo program and five ANDA actionsNov 6Weekly roundup, 8 itemsalbuterolduvakitug
Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
Sanofi registers Phase 2b hidradenitis suppurativa trial; RSV+HMPV vaccine study recruitingSep 10Weekly roundup, 2 itemsduvakitugSanofi
Teva posts Q2 2026 GAAP loss on Emalex charge, raises innovative brand outlookJul 29Quarterly updatedeutetrabenazinefremanezumab-vfrm